When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRXT - Clarus Therapeutics Q1 2022 Earnings Preview
Clarus Therapeutics Holdings Inc.
Clarus Therapeutics (NASDAQ:CRXT) Q1 consensus EPS estimate is -$0.35 and consensus revenue estimate is $4.95M. CRXT is scheduled to announce Q1 earnings results on Monday, May 16, after market close.